secwatch.observer — SEC 8-K summary
======================================

Issuer:     Curanex Pharmaceuticals Inc (CURX)
CIK:        0002025942
Form:       8-K
Filed at:   2026-08-17T20:45:24+00:00
Accession:  0001493152-26-038764
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Curanex Pharmaceuticals announces 1-for-20 reverse stock split effective Aug 20, 2026
--------------------------------------------------------------------------------

- 1-for-20 reverse stock split effective 12:01 a.m. PT on Aug 20, 2026; Nasdaq trading begins split-adjusted that day.
- Pre-split shares ~31,364,812; post-split ~1,568,241 shares outstanding.
- Purpose: regain compliance with Nasdaq's $1.00 minimum bid price rule (Listing Rule 5550(a)(2)).
- No fractional shares; fractional interests rounded up to whole share; new CUSIP number assigned.
- Authorized shares remain 475,000,000; par value $0.0001 unchanged; equity awards proportionally adjusted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2025942/000149315226038764/0001493152-26-038764-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2025942/000149315226038764/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-038764

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer